CRBU
Price
$2.63
Change
-$0.04 (-1.50%)
Updated
Oct 17 closing price
Capitalization
244.91M
23 days until earnings call
Intraday Buy/Sell Signals
FATE
Price
$1.47
Change
-$0.07 (-4.55%)
Updated
Oct 17 closing price
Capitalization
169.53M
11 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

CRBU vs FATE

Header iconCRBU vs FATE Comparison
Open Charts CRBU vs FATEBanner chart's image
Caribou Biosciences
Price$2.63
Change-$0.04 (-1.50%)
Volume$668.9K
Capitalization244.91M
Fate Therapeutics
Price$1.47
Change-$0.07 (-4.55%)
Volume$1.5M
Capitalization169.53M
CRBU vs FATE Comparison Chart in %
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. FATE commentary
Oct 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and FATE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 20, 2025
Stock price -- (CRBU: $2.63 vs. FATE: $1.47)
Brand notoriety: CRBU and FATE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 62% vs. FATE: 68%
Market capitalization -- CRBU: $244.91M vs. FATE: $169.53M
CRBU [@Biotechnology] is valued at $244.91M. FATE’s [@Biotechnology] market capitalization is $169.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileFATE’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • FATE’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRBU and FATE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 6 TA indicator(s) are bullish while FATE’s TA Score has 6 bullish TA indicator(s).

  • CRBU’s TA Score: 6 bullish, 4 bearish.
  • FATE’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both CRBU and FATE are a good buy in the short-term.

Price Growth

CRBU (@Biotechnology) experienced а +5.62% price change this week, while FATE (@Biotechnology) price change was -10.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

CRBU is expected to report earnings on Nov 11, 2025.

FATE is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($245M) has a higher market cap than FATE($170M). CRBU YTD gains are higher at: 65.409 vs. FATE (-10.909). CRBU has higher annual earnings (EBITDA): -150.76M vs. FATE (-161.6M). FATE has more cash in the bank: 223M vs. CRBU (184M). CRBU has less debt than FATE: CRBU (25.9M) vs FATE (81.3M). CRBU has higher revenues than FATE: CRBU (9.12M) vs FATE (8.47M).
CRBUFATECRBU / FATE
Capitalization245M170M144%
EBITDA-150.76M-161.6M93%
Gain YTD65.409-10.909-600%
P/E RatioN/AN/A-
Revenue9.12M8.47M108%
Total Cash184M223M83%
Total Debt25.9M81.3M32%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
45
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUFATE
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSGCF0.03N/A
+6.62%
NORTHSTAR GOLD CORP.
BKEAF1.56N/A
N/A
Bank of East Asia Limited
CIWV34.50N/A
N/A
Citizens Financial Corp. (WV)
WACMF5.50N/A
N/A
Wacom Co., Ltd.
GBERY76.06-0.14
-0.18%
Geberit AG

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-1.50%
CRSP - CRBU
57%
Loosely correlated
+1.05%
BEAM - CRBU
53%
Loosely correlated
+0.74%
MGNX - CRBU
53%
Loosely correlated
-2.37%
RXRX - CRBU
53%
Loosely correlated
-7.86%
NTLA - CRBU
51%
Loosely correlated
-0.64%
More